It’s important to taper steroid medications gradually to avoid unpleasant side effects, but tapering schedules will depend on individual needs and may differ for everyone. A doctor can work with ...

Compared with placebo, adding methotrexate nearly doubled steroid-free remission rates and reduced time to remission by 11 weeks.

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation volume, inhalation duration and time to peak, according to study ...

In the GCAptAIN trial (NCT04930094), Cosentyx was evaluated in combination with a 26-week steroid taper and compared to a placebo plus a 52-week steroid taper.

Last week two of the most disreputable beneficiaries of MLB’s and “Bottom Line” Bud Selig’s intentional neglect of what no one else could miss — MLB’s cheaters-prosper Steroid Era ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new ch… ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an approximately $10 billion deal.

The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

Novartis today announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).